(PTEN) Patterson-UTI Energy - Overview
Stock: Drilling, Completion, Bits, Motors, Wireline
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.27% |
| Yield on Cost 5y | 7.49% |
| Yield CAGR 5y | 41.42% |
| Payout Consistency | 87.7% |
| Payout Ratio | 213.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 47.2% |
| Relative Tail Risk | -6.41% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.38 |
| Alpha | -17.34 |
| Character TTM | |
|---|---|
| Beta | 1.916 |
| Beta Downside | 2.879 |
| Drawdowns 3y | |
|---|---|
| Max DD | 64.58% |
| CAGR/Max DD | -0.21 |
Description: PTEN Patterson-UTI Energy January 13, 2026
Patterson-UTI Energy Inc. (NASDAQ: PTEN) delivers drilling and completion services to oil and natural-gas producers through three operating segments: Drilling Services (contract and directional drilling, MWD, and related software), Completion Services (hydraulic fracturing, wireline, cementing, and ancillary power-logistics solutions), and Drilling Products (design, manufacture, and rental of polycrystalline-diamond-compact drill bits and other land-based tooling). The firm, founded in 1978 and based in Houston, also offers data-analytics tools such as HiFi Nav and HiFi Guidance that aim to improve well placement and trajectory optimization.
Key recent metrics indicate the company generated roughly $1.2 billion in revenue for Q4 2023, with an adjusted EBITDA margin near 15 %, reflecting the cyclical benefit of higher oil prices and a modestly rising on-shore rig count in the Permian and Eagle Ford basins. Capital expenditures have been focused on expanding its proprietary MWD platform and scaling the high-performance drill-bit product line, while the broader drilling sector remains sensitive to OPEC-plus production decisions and U.S. shale-drilling activity trends.
For a deeper, data-driven dive into PTEN’s valuation and risk profile, you may find the analytical tools on ValueRay worth exploring.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -93.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -1.84 > 1.0 |
| NWC/Revenue: 11.49% < 20% (prev 8.43%; Δ 3.06% < -1%) |
| CFO/TA 0.17 > 3% & CFO 961.2m > Net Income -93.6m |
| Net Debt (800.4m) to EBITDA (907.8m): 0.88 < 3 |
| Current Ratio: 1.64 > 1.5 & < 3 |
| Outstanding Shares: last quarter (379.2m) vs 12m ago -2.62% < -2% |
| Gross Margin: 4.72% > 18% (prev 0.05%; Δ 466.6% > 0.5%) |
| Asset Turnover: 84.65% > 50% (prev 92.19%; Δ -7.54% > 0%) |
| Interest Coverage Ratio: -0.46 > 6 (EBITDA TTM 907.8m / Interest Expense TTM 70.5m) |
Altman Z'' 1.35
| A: 0.10 (Total Current Assets 1.42b - Total Current Liabilities 863.6m) / Total Assets 5.57b |
| B: -0.22 (Retained Earnings -1.22b / Total Assets 5.57b) |
| C: -0.01 (EBIT TTM -32.5m / Avg Total Assets 5.70b) |
| D: 1.37 (Book Value of Equity 3.22b / Total Liabilities 2.35b) |
| Altman-Z'' Score: 1.35 = BB |
Beneish M -3.17
| DSRI: 0.98 (Receivables 723.3m/821.8m, Revenue 4.83b/5.38b) |
| GMI: 1.13 (GM 4.72% / 5.32%) |
| AQI: 1.04 (AQ_t 0.26 / AQ_t-1 0.25) |
| SGI: 0.90 (Revenue 4.83b / 5.38b) |
| TATA: -0.19 (NI -93.6m - CFO 961.2m) / TA 5.57b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of PTEN shares?
Over the past week, the price has changed by +14.10%, over one month by +23.19%, over three months by +42.78% and over the past year by +1.60%.
Is PTEN a buy, sell or hold?
- StrongBuy: 5
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PTEN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.7 | -11.5% |
| Analysts Target Price | 7.7 | -11.5% |
| ValueRay Target Price | 9.9 | 13.9% |
PTEN Fundamental Data Overview February 08, 2026
P/S = 0.6911
P/B = 0.9656
P/EG = 0.7785
Revenue TTM = 4.83b USD
EBIT TTM = -32.5m USD
EBITDA TTM = 907.8m USD
Long Term Debt = 1.22b USD (from longTermDebt, two quarters ago)
Short Term Debt = 65.3m USD (from shortTermDebt, two quarters ago)
Debt = 1.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 800.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.14b USD (3.34b + Debt 1.22b - CCE 420.6m)
Interest Coverage Ratio = -0.46 (Ebit TTM -32.5m / Interest Expense TTM 70.5m)
EV/FCF = 11.11x (Enterprise Value 4.14b / FCF TTM 372.2m)
FCF Yield = 9.00% (FCF TTM 372.2m / Enterprise Value 4.14b)
FCF Margin = 7.71% (FCF TTM 372.2m / Revenue TTM 4.83b)
Net Margin = -1.94% (Net Income TTM -93.6m / Revenue TTM 4.83b)
Gross Margin = 4.72% ((Revenue TTM 4.83b - Cost of Revenue TTM 4.60b) / Revenue TTM)
Gross Margin QoQ = 5.04% (prev 4.81%)
Tobins Q-Ratio = 0.74 (Enterprise Value 4.14b / Total Assets 5.57b)
Interest Expense / Debt = 1.45% (Interest Expense 17.7m / Debt 1.22b)
Taxrate = 21.0% (US default 21%)
NOPAT = -25.7m (EBIT -32.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.64 (Total Current Assets 1.42b / Total Current Liabilities 863.6m)
Debt / Equity = 0.38 (Debt 1.22b / totalStockholderEquity, last quarter 3.22b)
Debt / EBITDA = 0.88 (Net Debt 800.4m / EBITDA 907.8m)
Debt / FCF = 2.15 (Net Debt 800.4m / FCF TTM 372.2m)
Total Stockholder Equity = 3.31b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.64% (Net Income -93.6m / Total Assets 5.57b)
RoE = -2.83% (Net Income TTM -93.6m / Total Stockholder Equity 3.31b)
RoCE = -0.72% (EBIT -32.5m / Capital Employed (Equity 3.31b + L.T.Debt 1.22b))
RoIC = -0.56% (negative operating profit) (NOPAT -25.7m / Invested Capital 4.56b)
WACC = 9.81% (E(3.34b)/V(4.56b) * Re(12.98%) + D(1.22b)/V(4.56b) * Rd(1.45%) * (1-Tc(0.21)))
Discount Rate = 12.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.83%
[DCF Debug] Terminal Value 69.56% ; FCFF base≈422.2m ; Y1≈375.8m ; Y5≈315.3m
Fair Price DCF = 9.04 (EV 4.23b - Net Debt 800.4m = Equity 3.43b / Shares 379.2m; r=9.81% [WACC]; 5y FCF grow -13.53% → 2.90% )
EPS Correlation: -35.12 | EPS CAGR: 1.21% | SUE: 0.12 | # QB: 0
Revenue Correlation: 77.43 | Revenue CAGR: 24.28% | SUE: 0.68 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.11 | Chg30d=+0.005 | Revisions Net=+1 | Analysts=1
EPS current Year (2026-12-31): EPS=-0.42 | Chg30d=-0.034 | Revisions Net=+2 | Growth EPS=-75.0% | Growth Revenue=-9.3%
EPS next Year (2027-12-31): EPS=-0.17 | Chg30d=+0.010 | Revisions Net=+2 | Growth EPS=+59.5% | Growth Revenue=+8.2%